FDA NDC Directory · JSON-LD · Markdown

Ery-Ped

NDC 80005-155 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameErythromycin Ethylsuccinate
Labeler / ManufacturerCarnegie Pharmaceuticals LLC
Marketing categoryNew Drug Application (innovator) · App NDA050207
Dosage form / routeSUSPENSION · ORAL
Active ingredientsERYTHROMYCIN ETHYLSUCCINATE (400 mg/5mL)
Marketing started20250115
Package count1

External sources

Source: openFDA. Public-domain (CC0).